More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...
Generalized pustular psoriasis (GPP) is a rare, chronic, heterogenous neutrophilic inflammatory disease associated with skin and systemic symptoms, such as fever, pain, and fatigue.1,2,3,4SPEVIGO's ...
AGEP can closely mimic generalized pustular psoriasis (GPP), requiring histopathologic confirmation and assessment of peripheral eosinophilia.
Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma [ID2725] Draft guidance Technology appraisal guidance 25 February 2025 Tarlatamab for previously treated ...
Associations between therapies and quality of life (QoL) in patients with generalized pustular psoriasis (GPP) can differ substantially.
to pustules (pustular psoriasis) and generalised erythema and scale (erythrodermic psoriasis). In addition, these different forms of psoriasis may be localised or widespread and disabling. Further, ...
Jennison Associates LLC boosted its holdings in shares of AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) by 1.6% in the fourth quarter, according to the company in its most recent 13F filing with the ...
German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results